The renal metabolism of 25-hydroxyvitamin D3 in the rat: regulation by 1,25-dihydroxyvitamin D3.

The renal metabolism of 25-hydroxyvitamin D3 in the rat: regulation by 1,25-dihydroxyvitamin D3. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The renal metabolism of 25-hydroxyvitamin D3 in the rat: regulation by 1,25-dihydroxyvitamin D3. Abstract Text:

The renal metabolism of 25-hydroxyvitamin D3 in the rat: regulation by 1,25-dihydroxyvitamin D3. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The renal metabolism of 25-hydroxyvitamin D3 in the rat: regulation by 1,25-dihydroxyvitamin D3. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Calcified tissue international

VOLUME: 35

Page Numbers: 438-42

Journal Abbreviation: Calcif. Tissue Int.

ISSN: 0171-967X

DAY: 16

MONTH: Jul

YEAR: 1983

The renal metabolism of 25-hydroxyvitamin D3 in the rat: regulation by 1,25-dihydroxyvitamin D3. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7905481

The renal metabolism of 25-hydroxyvitamin D3 in the rat: regulation by 1,25-dihydroxyvitamin D3. Keywords Mesh Terms:

KEYWORDS: Vitamin D Deficiency

MESH TERMS: metabolism

Chemical & Substance for Abstract: The renal metabolism of 25-hydroxyvitamin D3 in the rat: regulation by 1,25-dihydroxyvitamin D3. Information

Substance Name: vitamin D 24-hydroxylase

Registry Number: EC 1.14.13.-

Grant and Affiliation Information for The renal metabolism of 25-hydroxyvitamin D3 in the rat: regulation by 1,25-dihydroxyvitamin D3.

AFFILIATION:

Country: GERMANY, WEST

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Calcif Tissue Int

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The renal metabolism of 25-hydroxyvitamin D3 in the rat: regulation by 1,25-dihydroxyvitamin D3 Related Publications

• ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts.
• Bone-derived factors active on bone cells.
• Bovine skeletal growth factor stimulates protein phosphorylation of chicken bone cells in vitro.
• Characterization of cells isolated and cultured from human bone.
• Chemical and biological characterization of low-molecular-weight human skeletal growth factor.
• Effect of bone matrix-derived growth factors on skull and tibia in the growing rat.
• Human skeletal growth factor stimulates collagen synthesis and inhibits proliferation in a clonal osteoblast cell line (MC3T3-E1).
• Human skeletal growth factor: characterization of the mitogenic effect on bone cells in vitro.
• In vitro metabolism of 25-hydroxyvitamin D3 by isolated rat kidney cells.
• Isolation and purification of a low-molecular-weight skeletal growth factor from human bones.
• Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II.
• Purification of a skeletal growth factor from human bone.
• Purification of bovine skeletal growth factor.
• Retroviral-based gene therapy with cyclooxygenase-2 promotes the union of bony callus tissues and accelerates fracture healing in the rat.
• Sca-1(+) hematopoietic cell-based gene therapy with a modified FGF-2 increased endosteal/trabecular bone formation in mice.
• Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells.
• Skeletal growth factor is produced by human osteoblast-like cells in culture.
• The diagnosis of osteoporosis.
• The renal metabolism of 25-hydroxyvitamin D3 in the rat: regulation by 1,25-dihydroxyvitamin D3.
• Vanadate stimulates bone cell proliferation and bone collagen synthesis in vitro.